CytoDyn unveils further clinical trial plans in bid to fight coronavirus pandemic

Credit: Proactive Investors- Published on May 18, 2020
CytoDyn Inc (OTCQB:CYDY) is set to submit a clinical trial design to the US FDA to compare the effectiveness of leronlimab versus remdesivir, and in combination with remdesivir for the treatment of coronavirus (COVID-19), it told investors on Monday. It comes as the firm is is currently enrolling patients in two clinical trials...
Advertisement

Video credit: Veuer
Published on May 19, 2020 -  00:51
Air Pollution in China Rises in May, Back to Pre-Lockdown Levels After Sharp Decline Due to the Coronavirus
Around the world air pollution levels decreased when countries put in place strict stay-at-home orders due to the coronavirus pandemic.

You are here


Related videos from verified sources

Coronavirus in numbers: UK death toll reaches 38,489 00:34
Credit: PA - Press Association STUDIO - Published on May 31, 2020 


DR Congo activists fight misinformation around COVID-19 02:10
Credit: Al Jazeera STUDIO - Published on May 31, 2020 


Call for economic support for Indian-administered Kashmir 02:55
Credit: Al Jazeera STUDIO - Published on May 31, 2020 


Related news from verified sources

CytoDyn Inc (OTCQB:CYDY) has announced plansΒ to work with the Mexican National Institutes of Health (NIH) on aΒ trial of leronlimab for severe coronavirus...
on May 19, 2020 • Proactive Investors

You might like